AJEMUSEL Trademark

Trademark Overview


On Thursday, August 4, 2022, a trademark application was filed for AJEMUSEL with the United States Patent and Trademark Office. The USPTO has given the AJEMUSEL trademark a serial number of 97534427. The federal status of this trademark filing is REGISTERED as of Tuesday, September 26, 2023. This trademark is owned by Glaxo Group Limited. The AJEMUSEL trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
ajemusel

General Information


Serial Number97534427
Word MarkAJEMUSEL
Filing DateThursday, August 4, 2022
Status700 - REGISTERED
Status DateTuesday, September 26, 2023
Registration Number7173662
Registration DateTuesday, September 26, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2023

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Tuesday, September 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 26, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 21, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 20, 2023EXAMINER'S AMENDMENT ENTERED
Saturday, May 20, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, May 20, 2023EXAMINERS AMENDMENT E-MAILED
Saturday, May 20, 2023EXAMINERS AMENDMENT -WRITTEN
Saturday, May 20, 2023ASSIGNED TO EXAMINER
Thursday, August 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 8, 2022NEW APPLICATION ENTERED